Probing cell signaling complexity in wound healing with engineered protein materials

Active Grant Awarded

Award ID
R35GM166453
Recipient
Awarding agency
Obligated
$390,500

Award facts

Assistance listing
93.859 Biomedical Research and Research Training
Completion date 5% complete
Place of performance
Portland, ME 04103, USA

Award details come from USAspending.gov.

About this award

The Department of Health and Human Services' National Institutes of Health, National Institute of General Medical Sciences, awarded University of New England $390,500 on August 24, 2026, under Grant R35GM166453 in the Biomedical Research and Research Training program (CFDA 93.859). The full $390,500 is obligated, the ultimate completion date is May 31, 2031, and performance takes place in Portland, ME 04103.

The project, titled "Probing Cell Signaling Complexity in Wound Healing with Engineered Protein Materials," uses a stimuli-responsive elastin-like protein polymer that binds VEGF receptor 1 (VEGFR1) and neuropilin-1 (NRP1). The recipient will measure binding affinity, kinetics, and stoichiometry of VEGFR1 and NRP1 across soluble, membrane-bound, and biomaterial-embedded ligand presentation states, and will examine how protein phase separation influences receptor interactions. It will also investigate the kidney as an internal model system for wound healing, including vascular signaling and inflammation, using glomerular filtration as a functional readout. Planned outputs include a suite of engineered protein tools for dynamic biomaterials and new models and methodologies for probing cell-cell communication through receptor-ligand interactions. Methods span biophysical, biochemical, cell-based, and physiological approaches.

The source describes no sub-recipients for this award. The program's stated purpose is NIGMS support for basic research that advances understanding of biological processes.

Description

Abstract
Fundamental questions in biology include how a protein's environment influences its function and how information flows from the interactions of proteins with their ligands. We use engineered proteins and protein- based materials to investigate these questions through biophysical, biochemical, cell-based, and physiological approaches. We have developed a stimuli-responsive elastin-like protein polymer that binds vegf receptor 1 (VEGFR1) and neuropilin-1 (NRP1) and influences vascular endothelial cell survival in vitro. Using this tool and related rationally-designed protein materials, we will investigate how ligand presentation-soluble, membrane- bound, or within biomaterials-affects receptor binding, signaling, and trafficking. We will measure binding affinity, kinetics, and stoichiometry of VEGFR1 and NRP1 in different presentation state and explore the influence of protein phase separation on receptor interactions. Additionally, we have observed that our polymer accelerates recovery from wound pain in mice, providing an opportunity to refine protein biomaterials-based approaches to understanding the pleiotropic functions of VEGFR1 and NRP1 in pain. Our polymer also localizes to the kidney upon systemic administration in mice. Given the kidney's complex microvasculature and the availability of glomerular filtration as a well-defined, non-invasive functional readout, we will investigate the potential of the kidney as an internal model system for studying wound healing, including vascular signaling and inflammation. The successful completion of this work will advance fundamental understanding of protein- receptor interactions in different molecular contexts, develop a suite of engineered protein tools for dynamic biomaterials, and establish new models and methodologies for probing cell-cell communication through receptor-ligand interactions. By advancing our understanding of protein-receptor interactions and biomaterial- based signaling modulation, this work will provide new molecular frameworks and methodological tools applicable across diverse biological systems.

Quick answers

Who received award R35GM166453?

R35GM166453 was awarded to University Of New England by National Institute of General Medical Sciences (National Institutes of Health) on August 24, 2026.

How much is award R35GM166453 worth?

$390,500 has been obligated on R35GM166453.

On GovTribe

See this award's full record

  • Every transaction and subaward
  • The recipient's other awards and teaming partners
  • Similar grant awards
  • Ask GovTribe AI about this award